# EDGAR Filing Document

**Accession Number:** 0000320351
**File Stem:** 0000035402-26-002667
**Filing Date:** 2026-4
**Character Count:** 24106
**Document Hash:** 3c6b4b98cc013283a8e1be766be41ebe
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000035402-26-002667.hdr.sgml**: 20260424

**ACCESSION NUMBER**: 0000035402-26-002667

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260424

**DATE AS OF CHANGE**: 20260424

**PERIOD START**: 20260228

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIDELITY SELECT PORTFOLIOS
- **CENTRAL INDEX KEY:** 0000320351

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-03114
- **FILM NUMBER:** 26895566

**BUSINESS ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 617-563-7000

**MAIL ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

## Series and Classes Contracts Data

### Pharmaceuticals Portfolio (Series ID: S000007481)

| Class ID   | Class Name                | Ticker Symbol   |
|:---|:---|:---|
| C000020455 | Pharmaceuticals Portfolio | FPHAX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Fidelity Select Portfolios

- **b. Investment Company Act file number:** 811-03114

- **c. CIK number of Registrant:** 0000320351

- **d. LEI of Registrant:** Z57125JG1LHEQKDYS630

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 245 Summer Street

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 1-800-FIDELITY

**Item A.2. Information about the Series.**

- **a. Name of Series:** Select Pharmaceuticals Portfolio

- **b. EDGAR series identifier (if any):** S000007481

- **c. LEI of Series:** MN21BN6DBQP38HPMPO32

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-02-28

- **b. Date as of which information is reported:** 2026-02-28

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1588930547.94

**Total Liabilities:** $73122184.17

**Net Assets:** $1515808363.77

**Cash Not Reported:** $1050952.54

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000020455 | -1.38%               | 2.20%                | 5.38%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $11587538.59             | $-30398279.30                              |
| Month 2  | $-4159035.26             | $35219608.68                               |
| Month 3  | $43842863.31             | $30253579.30                               |

### Schedule of Portfolio Investments

| Name                                   | Title                                                | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ARROWHEAD PHARMACEUTICALS INC          | ARROWHEAD PHARMACEUTICALS INC                        | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |     65400 | NS      | $4137858.00   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| ASCENDIS PHARMA A/S                    | ASCENDIS PHARMA AS SPON ADR                          | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |     24400 | NS      | $5697400.00   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| ASTRAZENECA PLC                        | ASTRAZENECA PLC                                      | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |    358250 | NS      | $74677212.50  | 4.93%             |  |  |  | No            |                  1 | On Loan: No      |
| AXSOME THERAPEUTICS INC                | AXSOME THERAPEUTICS INC                              | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     48900 | NS      | $8014221.00   | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| BIOGEN INC                             | BIOGEN INC                                           | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     73000 | NS      | $14002860.00  | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| CAPRICOR THERAPEUTICS INC              | CAPRICOR THERAPEUTICS INC                            | CUSIP: 14070B309<br>LEI: 5493002ZI5PDLXV4DX14 | Long             | EC               | CORP              | US        |    389900 | NS      | $10889907.00  | 0.72%             |  |  |  | No            |                  1 | On Loan: —       |
| CORCEPT THERAPEUTICS INC               | CORCEPT THERAPEUTICS INC                             | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |    158100 | NS      | $5644170.00   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Revere Street Trust           | Fidelity Cash Central Fund                           | CUSIP: 31635A105<br>LEI: 549300BDV45LJNXBZC55 | Long             | STIV             | RF                | US        |   4809384 | NS      | $4810346.21   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Revere Street Trust           | Fidelity Securities Lending Cash Central Fund        | CUSIP: 31635A303<br>LEI: 549300BDV45LJNXBZC55 | Long             | STIV             | RF                | US        |  64528911 | NS      | $64535363.81  | 4.26%             |  |  |  | No            |                  1 | On Loan: No      |
| FINANCIERE DE TUBIZE SA                | FINANCIERE DE TUBIZE SA                              | CUSIP: N/A<br>LEI: 549300I1MGC0OK6W8828       | Long             | EC               | CORP              | BE        |     91587 | NS      | $24511648.56  | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| GILEAD SCIENCES INC                    | GILEAD SCIENCES INC                                  | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    472500 | NS      | $70378875.00  | 4.64%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                                | GSK PLC SPONS ADR                                    | CUSIP: 37733W204<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |   2581360 | NS      | $152635816.80 | 10.07%            |  |  |  | No            |                  1 | On Loan: No      |
| JAZZ PHARMACEUTICALS PLC               | JAZZ PHARMA PLC                                      | CUSIP: N/A<br>LEI: 635400GAUMJCLEZRRV50       | Long             | EC               | CORP              | IE        |    227700 | NS      | $43267554.00  | 2.85%             |  |  |  | No            |                  1 | On Loan: No      |
| IONIS PHARMACEUTICALS INC              | IONIS PHARMACEUTICALS INC                            | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |       100 | NS      | $8115.00      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| JOHNSON and JOHNSON                    | JOHNSON and JOHNSON                                  | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    459700 | NS      | $114203271.00 | 7.53%             |  |  |  | No            |                  1 | On Loan: No      |
| ELI LILLY and CO                       | ELI LILLY and CO                                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    362801 | NS      | $381663023.99 | 25.18%            |  |  |  | No            |                  1 | On Loan: No      |
| MEDAVAIL HOLDINGS INC                  | MEDAVAIL HOLDINGS INC PIPE                           | CUSIP: N/A<br>LEI: 549300ZNQGSJ2V3ZB668       | Long             | EC               | CORP              | US        |        66 | NS      | $0.01         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| MERCK and CO INC                       | MERCK and CO INC NEW                                 | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    561536 | NS      | $69529387.52  | 4.59%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK KGAA                             | MERCK KGAA                                           | CUSIP: N/A<br>LEI: 529900OAREIS0MOPTW25       | Long             | EC               | CORP              | DE        |     94700 | NS      | $14348541.37  | 0.95%             |  |  |  | No            |                  2 | On Loan: No      |
| UNIQURE N.V.                           | UNIQURE N.V.                                         | CUSIP: N/A<br>LEI: 724500RPCTZLFYJZ3S98       | Long             | EC               | CORP              | NL        |    705578 | NS      | $11028184.14  | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| OCULAR THERAPEUTIX INC                 | OCULAR THERAPEUTIX INC                               | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |   1331717 | NS      | $11905549.98  | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC THERAPEUTICS INC                   | PTC THERAPEUTICS INC                                 | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    155600 | NS      | $10610364.00  | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| PHIBRO ANIMAL HEALTH CORP              | PHIBRO ANIMAL HEALTH CORP CL A                       | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |    150755 | NS      | $8229715.45   | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| ROCHE HOLDING AG                       | ROCHE HOLDINGS AG (GENUSSCHEINE)                     | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |    157090 | NS      | $74759359.77  | 4.93%             |  |  |  | No            |                  2 | On Loan: No      |
| WAVE LIFE SCIENCES LTD                 | WAVE LIFE SCIENCES LTD                               | CUSIP: N/A<br>LEI: 54930070006GPKFYZ813       | Long             | EC               | CORP              | SG        |    296800 | NS      | $4134424.00   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| INTELLIA THERAPEUTICS INC              | INTELLIA THERAPEUTICS INC                            | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |    384500 | NS      | $5298410.00   | 0.35%             |  |  |  | No            |                  1 | On Loan: —       |
| UCB SA                                 | UCB SA                                               | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |    254500 | NS      | $75870949.38  | 5.01%             |  |  |  | No            |                  1 | On Loan: No      |
| VIKING THERAPEUTICS INC                | VIKING THERAPEUTICS INC                              | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |     64300 | NS      | $2175912.00   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| XENON PHARMACEUTICALS INC              | XENON PHARMACEUTICALS INC                            | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |    268600 | NS      | $11611578.00  | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| MODERNA INC                            | MODERNA INC                                          | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    688800 | NS      | $36899016.00  | 2.43%             |  |  |  | No            |                  1 | On Loan: —       |
| IDORSIA LTD                            | IDORSIA LTD                                          | CUSIP: N/A<br>LEI: 506700XOVZUB107S5720       | Long             | EC               | CORP              | CH        |    639660 | NS      | $3257161.87   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| CRINETICS PHARMACEUTICALS INC          | CRINETICS PHARMACEUTICALS INC                        | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |    122800 | NS      | $5047080.00   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| ELANCO ANIMAL HEALTH INC               | ELANCO ANIMAL HEALTH INC                             | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |   2536200 | NS      | $66955680.00  | 4.42%             |  |  |  | No            |                  1 | On Loan: No      |
| BIONTECH SE                            | BIONTECH SE ADR                                      | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |    132653 | NS      | $14622340.19  | 0.96%             |  |  |  | No            |                  1 | On Loan: —       |
| CASTLE CREEK BIOSCIENCES INC           | CASTLE CREEK BIOSCIENCES INC SER C PC PERP PP        | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |       200 | NS      | $51036.00     | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| BEAM THERAPEUTICS INC                  | BEAM THERAPEUTICS INC                                | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    415400 | NS      | $11822284.00  | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| DEFINIUM THERAPEUTICS INC              | DEFINIUM THERAPEUTICS INC                            | CUSIP: 24477V105<br>LEI: 529900UG3DGE202N5D44 | Long             | EC               | CORP              | CA        |    188000 | NS      | $3280600.00   | 0.22%             |  |  |  | No            |                  1 | On Loan: —       |
| LEGEND BIOTECH CORP                    | LEGEND BIOTECH CORP SPON ADR                         | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | KY        |   2598400 | NS      | $49369600.00  | 3.26%             |  |  |  | No            |                  1 | On Loan: —       |
| ROYALTY PHARMA PLC                     | ROYALTY PHARMA PLC                                   | CUSIP: N/A<br>LEI: 549300FGFN7VOK8BZR03       | Long             | EC               | CORP              | GB        |    750500 | NS      | $34680605.00  | 2.29%             |  |  |  | No            |                  1 | On Loan: No      |
| ANNEXON INC                            | ANNEXON INC                                          | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1264100 | NS      | $7078960.00   | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| HARMONY BIOSCIENCES HOLDINGS INC       | HARMONY BIOSCIENCES HOLDINGS INC                     | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    158577 | NS      | $4525787.58   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| DISC MEDICINE INC                      | DISC MEDICINE INC                                    | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53800 | NS      | $3584156.00   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| KYMERA THERAPEUTICS INC                | KYMERA THERAPEUTICS INC                              | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    102000 | NS      | $9317700.00   | 0.61%             |  |  |  | No            |                  1 | On Loan: —       |
| SUMMIT THERAPEUTICS INC                | SUMMIT THERAPEUTICS INC                              | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    169304 | NS      | $2808753.36   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| VERA THERAPEUTICS INC                  | VERA THERAPEUTICS INC                                | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    100700 | NS      | $4107553.00   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| VIATRIS INC                            | VIATRIS INC                                          | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   1729600 | NS      | $25822928.00  | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER C PC PP   | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |    158879 | NS      | $1480752.28   | 0.10%             |  |  |  | Yes           |                  3 | On Loan: No      |
| EDGEWISE THERAPEUTICS INC              | EDGEWISE THERAPEUTICS INC                            | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     83600 | NS      | $2544784.00   | 0.17%             |  |  |  | No            |                  1 | On Loan: —       |
| EVOZYNE INC                            | EVOZYNE INC SER A PC PP                              | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      5900 | NS      | $97114.00     | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| AMYLYX PHARMACEUTICALS INC             | AMYLYX PHARMACEUTICALS INC                           | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    257800 | NS      | $3910826.00   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| CASTLE CREEK BIOSCIENCES INC           | CASTLE CREEK BIOSCIENCES INC SER D-1 PC PP           | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      6308 | NS      | $1418038.40   | 0.09%             |  |  |  | Yes           |                  3 | On Loan: No      |
| CASTLE CREEK BIOSCIENCES INC           | CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP           | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |        85 | NS      | $17048.45     | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-1 PC PP | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |     15977 | NS      | $149544.72    | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-2 PC PP | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |     22477 | NS      | $196898.52    | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| EVOZYNE INC                            | EVOZYNE INC CPIK 6% 09/13/2028 P/P                   | CUSIP: N/A<br>LEI: N/A                        | Long             | DBT              | CORP              | US        |   1009196 | PA      | $1194383.30   | 0.08%             | 2028-09-13      | Fixed         | 0.06%                 | Yes           |                  3 | On Loan: No      |
| EVOZYNE INC                            | EVOZYNE INC SER B PC PP                              | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |     56643 | NS      | $960098.85    | 0.06%             |  |  |  | Yes           |                  3 | On Loan: No      |
| ARRIVENT BIOPHARMA INC                 | ARRIVENT BIOPHARMA INC                               | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    107000 | NS      | $2457790.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-3 PC PP | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      4581 | NS      | $47092.68     | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| AGOMAB THERAPEUTICS SA                 | AGOMAB THERAPEUTICS SA ADR                           | CUSIP: 00860C102<br>LEI: 894500APP6UE5N4PKJ68 | Long             | EC               | CORP              | BE        |      9100 | NS      | $145782.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| AGOMAB THERAPEUTICS SA                 | AGOMAB THERAPEUTICS SA (180 DAY LOCK-UP)             | CUSIP: N/A<br>LEI: 894500APP6UE5N4PKJ68       | Long             | EC               | CORP              | BE        |    332858 | NS      | $5332386.09   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-30

**Name of Applicant:** Stacie M. Smith

**Signature:** Stacie M. Smith

**Name of Signer:** Stacie M. Smith

**Title:** President and Treasurer